A Rre Story
We Believe In Our Future.
A Rre Commitment
To Ensuring Patient Access to Medicines.
Michael, 25 Living with Fabry Disease
We are a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare diseases.
News & Announcements
Executive Chairman, John F. Crowley Delivers Notre Dame Commencement Address.
Programs & Pipeline
We are leveraging our innovative technology platforms to develop treatments for human genetic diseases.